Astera Labs (NASDAQ:ALAB) Trading Down 8.5% – Here’s What Happened

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded down 8.5% during trading on Thursday . The stock traded as low as $192.33 and last traded at $195.65. 6,505,664 shares were traded during mid-day trading, an increase of 21% from the average session volume of 5,395,744 shares. The stock had previously closed at $213.91.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: JPMorgan raised its price target on Astera Labs to $280 from $205 and kept an overweight rating, signaling strong confidence in further upside after the company’s latest results. Benzinga
• Positive Sentiment: Needham lifted its price target to $260, while other reports cited positive forecasts from JPMorgan and Stifel, adding to the bullish analyst momentum around ALAB. Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00 at Needham & Company LLC
• Positive Sentiment: Commentary around the stock highlighted Astera Labs as a long-term momentum name and a beneficiary of AI connectivity demand, suggesting investors see durable growth tied to datacenter buildouts and server interconnect products. Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
• Positive Sentiment: Several pieces emphasized strong AI connectivity demand and Scorpio expansion, with upbeat takes on the company’s positioning in the datacenter market helping support the stock. Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
• Neutral Sentiment: Post-earnings analysis was mixed: bulls pointed to strong growth, but critics noted rising costs, competition, and a premium valuation, which could cap near-term upside. Should Investors Buy, Hold, or Sell ALAB Stock Post Q1 Earnings?
• Neutral Sentiment: Astera Labs’ Q1 2026 earnings transcript kept attention on the company’s strong revenue growth and guidance, but the transcript itself does not add a new catalyst beyond the already reported results. Astera Labs (ALAB) Q1 2026 Earnings Transcript
• Negative Sentiment: The main downside risk is valuation: after a strong run and multiple target hikes, some investors may worry the stock already prices in a lot of future growth.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Weiss Ratings upgraded shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday. Royal Bank Of Canada boosted their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday. Susquehanna raised their target price on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday. Citigroup raised their target price on Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, UBS Group began coverage on Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 target price for the company. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $229.65.

Astera Labs Stock Performance

The firm has a market capitalization of $34.25 billion, a PE ratio of 134.99, a price-to-earnings-growth ratio of 3.23 and a beta of 3.35. The business’s 50 day moving average is $143.77 and its two-hundred day moving average is $153.99.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 1.48 EPS for the current year.

Insider Buying and Selling

In related news, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel owned 118,084 shares of the company’s stock, valued at approximately $12,725,912.68. The trade was a 7.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,064,888 shares of company stock worth $150,764,723. Company insiders own 12.50% of the company’s stock.

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently modified their holdings of ALAB. Nordea Investment Management AB purchased a new position in Astera Labs in the 4th quarter worth approximately $2,028,000. Geneva Partners LLC purchased a new position in Astera Labs in the 3rd quarter worth approximately $1,876,000. Numerai GP LLC grew its stake in Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after buying an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB grew its stake in Astera Labs by 289.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after buying an additional 93,800 shares in the last quarter. Finally, Paragon Advisors LLC purchased a new position in Astera Labs in the 3rd quarter worth approximately $1,829,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.